Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel

Introduction: Conventional anti-androgen regimens were widely used as an initiation or combined androgen blockade (CAB) therapy in advanced prostate cancer patients. Currently, new androgen pathway inhibitors such as abiraterone acetate (AA) and enzalutamide had been proven effective in metastatic c...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Pharmacol
Main Authors: Li, Jian-Ri, Chiu, Kun-Yuan, Wang, Shian-Shiang, Yang, Cheng-Kuang, Chen, Chuan-Shu, Ho, Hao-Chung, Hung, Chi-Feng, Cheng, Chen-Li, Yang, Chi-Rei, Chen, Cheng-Che, Wang, Shu-Chi, Lin, Chia-Yen, Chang, Chao-Hsiang, Hsu, Chiann-Yi, Ou, Yen-Chuan
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2017
Fag:
Pharmacology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5702804/
https://ncbi.nlm.nih.gov/pubmed/29213237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00836
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker